Cardiovascular complications of diabetes mellitus: What we know and what we need to know about their prevention

Annals of Internal Medicine

Volumn 124, Issue 1 II, 1996, Pages 123-126

  Savage, Peter J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ANTICOAGULANT THERAPY; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CONFERENCE PAPER; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN TREATMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; TREATMENT PLANNING;

EID: 0030033975     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_2-199601011-00008     Document Type: Conference Paper

References (29)

1. American Diabetes Association. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes Diabetes Care 1989,12 573-9.
2. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study Am J Epidemiol 1983;118:489-96
3. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors the Framingham study Circulation 1979,59 8-13
4. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry Honolulu Heart Program Diabetes 1987;36:689-92
5. Harris MI, Entmacher PS. Mortality from diabetes. In: Harris MI, Hamman RF, eds Diabetes in America. U.S Government Printing Office, NIH publication no 85-1468, 1985:1-48
6. Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR, et al. Trends in diabetes and diabetic complications, 1980-1987 Diabetes Care 1992,15 960-7.
7. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population Sixteen-year follow-up study. Diabetes. 1974,23.105-11
8. International Collaborative Group. Joint discussion glycemia and CVD J Chronic Dis 1979;32 829-37
9. Schneider EL, Guralnik JM. The aging of America impact on health care costs. JAMA. 1990;263.2335-40
10. Smith JW, Marcus FI, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984,54 718-21
11. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure the Framingham study Am J Cardiol 1974,34 29-34.
12. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke: the Honolulu Heart Program JAMA 1987;257.949-52
13. Melton LJ 3d, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients Diabetes Care. 1980;3 650-4.
14. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44
15. Getz GS. Report on the workshop on diabetes and mechanisms of atherogenesis September 17th and 18th, 1992, Bethesda, Maryland Arterioscler Thromb. 1993,13:459-64
16. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994, 43:960-7
17. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990,263 2893-8
18. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc Natl Acad Sci USA 1994,91.9441-5
19. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med. 1993,329 977-86
20. Reaven GM. Role of insulin resistance in human disease Diabetes 1988; 37 1595-607.
21. Nolan JJ, Ludvik V, Beerdsen P, Joyce M, Olfesky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N Engl J Med. 1994,331 1188-93.
22. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
23. Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII Mortality and selected nonfatal events with insulin treatment JAMA 1978,240:37-42.
24. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock CP, et al. VA cooperative study on glycemic control and complications in type II diabetes (VACSDM) Diabetes Care [In press]
25. Smith DA. Comparative approaches to risk reduction of coronary heart disease in Tecumseh non-insulin-dependent diabetic population. Diabetes Care. 1986,9.601-8
26. UK Prospective Diabetes Study (UKPDS) VIII Study design, progress and performance Diabetologia 1991,34:877-90
27. Harris MI, Eastman RC, Siebert C. The DCCT and medical care for diabetes in the U.S Diabetes Care 1994,17 761-4
28. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994,23:145-58, discussion 159-60
29. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994,89 1333-445